Technology

Dr. Rob Kiltz's struggles, triumphs and vision [] The doctor fixing healthcare's information crisis eyes the fertility sector

Also in this issue:
The Digital Doctor: How Dr. C. Anthony Jones is Fixing Healthcare’s Information Crisis
Continue reading below

 
 

Dr. Robert Kiltz, founder of CNY Fertility and avid potter, blends Western medicine and holistic practices–with a side of steak–in his quest to make fertility more accessible and affordable.

By Tara Bellucci

In the world of fertility medicine, where treatments often come with hefty price tags, Dr. Robert Kiltz stands out for making fertility care accessible and affordable. As the founder and director of CNY Fertility, Kiltz has disrupted the delivery of reproductive medicine by integrating holistic practices with traditional treatments, all while keeping costs manageable for his patients. His journey from a struggling student to a pioneering fertility specialist is marked by a pursuit of innovation and inclusivity.

Youthful struggles

Today, his life in central New York is very different from his early years growing up in Los Angeles. The author of multiple books, including The Fertile Feast: Dr. Kiltz’s Essential Guide to a Keto Way of Life, started off as a struggling student that couldn’t read. “I couldn’t read, until I had to. I was kicked out of school…I didn’t get into medical school the first time,” he says. “These experiences made me resilient.”


“Healing isn’t just strictly with shots, pills, and surgeries.”


And those weren’t the only challenges of his youth. “I was arrested in a gang,” he shares. But a young Rob Kiltz found pottery, an outlet for stress and anxiety that he’s kept up to this day. “I bought a potter's wheel in high school. I still have it. And it's always a place to go when I need to.” Over his 55-plus years as an accomplished artist and potter, he’s created everything from tea sets to large platters, though his favorite thing to make are cups which at one point he even sold on Etsy. “Pottery is something pretty amazing in that you take mud and it forms into something,” he muses. “It’s a place for me to de-stress, refocus, and clear my mind.”​​

 
 

Flying is another of Kiltz’s passions. Having become a pilot 12 years ago, he finds parallels between aviation and his medical practice. “In the operating room, if you’ve got a bleeder, you just put pressure on it, take a breath, and then move forward,” he explains. “Our breath is so powerful.”​​ This ability to stay calm under pressure is a trait he values highly, whether navigating the skies or performing delicate medical procedures.


“Clinicians frequently overestimate patients' understanding and recall of instructions, while patients, even when confused, hesitate to admit their lack of comprehension.”

Next article, continue reading ↓


Helping vs. hurting

Stress management is something he also looks to provide to his patients. “[Western] medicine can be very stressful,” Kiltz admits. “We go into a health practice to help people, but we often find that it doesn’t work, and sometimes it hurts people.”​​ This realization has driven Kiltz to explore alternative therapies, including acupuncture, massage, meditation, and yoga. He believes these practices can alleviate the emotional and physical stress that often accompanies fertility treatments, providing a more comprehensive approach to patient care​​.

Kiltz’s personal struggles with health issues, including migraines, dyslexia, depression, and anxiety, fueled his interest in holistic health. “Through the years, it got worse,” he says, listing a litany of ailments from bowel bleeding to kidney stones​​. His quest for relief led him to adopt a ketogenic diet and eventually the Carnivore diet, which he credits with transforming his health and well-being. “I went to strictly a meat-based diet, eliminated plants of any significance or frequency, and I suddenly felt better.”​​

Eat meat

While the scientific community at large has concerns about keto and its more restrictive carnivore version, Dr. Kiltz is his own proof. After noticing patients who practiced keto diets having improved fertility results, the doctor left his omnivorous, Mediterranean-style eating habits behind. He says this dietary shift not only improved his own health, but also became a cornerstone of his practice.

Despite others who may not agree with his strategy, Kiltz advocates for a high-fat, low-carbohydrate diet, emphasizing the importance of ketosis—a metabolic state where the body burns fat for fuel instead of carbohydrates. “Ketosis is very anti-inflammatory and helps heal a lot of diseases,” he explains, suggesting that our modern diet, rich in processed foods and frequent meals, is a primary cause of many chronic illnesses​. “That’s why I talk a lot about nutrition and meditation and other modalities, because what if we can help you remove the cause of your diseases and infertility, and you don't need us? I’m committed to that.”

 
 

Kiltz’s approach to medicine is deeply spiritual, reflecting a journey from Catholicism to a broader spiritual philosophy. “Spirituality is a big part of my life and my practice,” he shares. “It helps me stay grounded and connected with my patients on a deeper level.” This spiritual perspective permeates his work, as he encourages patients to adopt a positive mindset and incorporate faith into their healing processes. “Faith, in whatever form it takes, is essential for healing,” he says. “It’s about believing in something greater than ourselves.”​​

Removing barriers

One of the defining features of Kiltz’s practice is its affordability. He says he has made it a mission to provide high-quality fertility treatments at a fraction of the cost. “Our goal is to make fertility care accessible to everyone,” he says. “We believe that financial barriers should not stand in the way of building a family.”​​ This philosophy is reflected in the pricing structure at CNY Fertility, where treatments are offered at significantly lower rates than the national average, and the practice offers interest-free self-financing to those patients who need it.

“Just because you have more money than someone else doesn't mean you have more of a right to have a family,” says Justine Taylor, Clinical Chief Nursing Officer at CNY Fertility, who has been working with Dr. Kiltz for 18 years. “And he truly believes that.”

“Our business model is focused on efficiency and affordability. We constantly look for ways to reduce expenses and pass those savings on to our patients,” says Kiltz. Through bundling services and streamlining processes, his team makes it happen. “We work hard to keep our costs low without sacrificing the quality of care. It’s a delicate balance, but it’s essential for our patients.”

Accessibility is also a huge focus. The company currently has eight locations across the US with more in the works.

Kiltz’s unique blend of holistic practices and conventional medicine has not only set him apart in the fertility field, but also garnered him a dedicated following. He has amassed over 300,000 followers across social media, where regularly goes live on Instagram at 5 a.m. to chat to his carnivore community. His patients appreciate his willingness to explore every possible avenue to improve their chances of conception. “We incorporate nutrition, faith, positivity—love yourself, love the environment, love your life,” he says, summarizing his philosophy​​.


“We believe that financial barriers should not stand in the way of building a family.”


“He gives everyone a chance,” Christina Salzberg, COO of CNY Fertility, says. And that was the case with a couple she knew. 20-plus years ago, IVF was even less accessible, relegated to celebrities and the pages of People magazine. Salzberg shares that back then, her friends dealt with a genetic disease that impacted their ability to conceive naturally. When other doctors were turning them away, not knowing if having embryos share a tank that were possible carriers might have a larger impact (which is not an issue today, of course), “Dr. Kiltz was like, ‘that’s ridiculous, I can do it, send them here.’ And they have two beautiful children today.”

Looking ahead, Kiltz remains committed to pushing the boundaries of fertility medicine. He continues to advocate for a holistic approach, believing that true health comes from a combination of physical, emotional, and spiritual well-being. “Healing isn’t just strictly with shots, pills, and surgeries,” he asserts. “We have to look at a lot of these ancient modalities and how they help humanity.”​​

In a field often focused on the latest technological advancements, Dr. Robert Kiltz’s holistic and affordable approach offers an additional perspective. While some of his methods are considered controversial, his career is a testament to the power of integrating mind, body, and spirit in the pursuit of health.

The content and themes expressed within the article above are that of the news. The advertiser does not have editorial control over the content of the previous article, and Inside Reproductive Health maintains full editorial independence. The views and opinions expressed in this article do not represent the views of the Advertiser or of Inside Reproductive Health.


And what he plans to do in the fertility space…

By: Inside Reproductive Health

In the hushed corridors of medical innovation, where the clash between innovation in patient care and business often sparks as much friction as it does progress, stands a physician-entrepreneur.

Dr. C. Anthony Jones’ journey from medical school to the helm of Frontive  is a narrative woven with the threads of necessity, punctuated by a singular mission: to transform healthcare information management.

Dr. Jones’ fascination with the failings of the healthcare system began in medical school. He found himself increasingly distracted by a recurring theme: the pervasive disarray in how medical information was managed.

Errors, ranging from scheduling mishaps to potentially fatal miscommunications, seemed to sprout from the chaotic handling of data.

The urgency of these issues led him to a pivotal decision: eschew a traditional residency in favor of a postdoctoral fellowship in medical informatics at Columbia University.

Dr. Jones’ professional trajectory took him through large consulting firms and burgeoning healthtech companies, each step marked by a relentless pursuit of making the healthcare experience smoother, more intuitive, and cost-effective.

From this foundational experience emerged Frontive, a venture that Dr. Jones regards as a natural progression in his career.

The inception of Frontive was not without its tribulations. Startups, particularly in the unforgiving arena of healthcare, are fraught with challenges.


Exclusive Pilot Opportunity-FREE for One Group Only

Choosing only one fertility clinic or network, Frontive Health, led by Dr. C. Anthony Jones, wants to replicate the results they’ve achieved in other healthcare sectors in the fertility space.

  • 60% Reduction in Patient Questions

  • 25% Reduction In Nurse Time

  • 20% increase in patient satisfaction

Dr. Jones is willing to pilot Frontive Health’s program for free…. But for only one fertility clinic network.

One clinic or network will receive several thousand dollars in value for free, but they must be innovative leaders and have an integrative EMR.

To see if your group qualifies, simply e-mail Dr. Jones and say hello.


FUNDING, FOCUS, AND FEAR

The so-called three Fs—funding, focus, and fear—loom large, but for Dr. Jones, the real adversary was the entrenched skepticism of healthcare providers. Their default posture of caution, while vital for patient safety, often becomes a barrier to the adoption of genuinely transformative technologies.

Dr. Jones approached this skepticism with a methodical strategy: focus on solving substantial problems, delve into the nuances of these issues from multiple perspectives, and substantiate claims with rigorous data.

Following a minor outpatient procedure, he observed the disorienting confusion faced by patients and their families as they navigated the whirlwind of pre-op and post-op instructions. The disheartening realization was that even educated individuals struggled to grasp the often convoluted instructions they received.

This was exacerbated for non-native English speakers, who battled not only a knowledge gap but a language barrier. What struck Dr. Jones was not just the confusion but the reluctance of patients to seek clarification, driven by a fear of seeming uninformed or judged by their clinicians.

This observation led to a profound insight: clinicians frequently overestimate patients' understanding and recall of instructions, while patients, even when confused, hesitate to admit their lack of comprehension.

 
 

DATA AND INTEGRATION

Addressing this disconnect became a central focus of Frontive, where digitization was employed not as a goal but as a means to deliver clarity, timeliness, and personalization.

Frontive Health™, the company’s flagship product, employs a novel approach to information personalization and dissemination. It dissects each physician’s  clinical instructions into digestible pieces, creating a repository of searchable FAQs and integrating real-time data to generate a daily Health Briefing™. This briefing—categorized into what to expect, what to do, and what to avoid—is dynamically tailored to the patient’s journey, streamlining information delivery and enhancing patient autonomy.

By interfacing directly with practices’  electronic health records (EHRs), the platform works seamlessly with a clinic’s workflow and ensures that patients receive accurate and timely information, thus alleviating staff burden and improving overall efficiency.

The success of Frontive Health™ is illustrated by a compelling case study with a cosmetic surgery practice. After implementing the platform, the practice saw a 60% reduction in patient inquiries and a 20% increase in satisfaction. More remarkably, the practice was able to cut its front-desk staff in half, reallocating resources to new patient intake and consultations, which in turn bolstered revenue and staff satisfaction. These metrics underscore not only the platform’s effectiveness but also its role as a strategic asset in a competitive market.

VISION FOR THE FERTILITY SPACE

Now, Dr. Jones’ vision extends into the realm of fertility medicine, a field rife with emotional and procedural complexities. Here, Frontive aims to mitigate patient anxiety and streamline protocol adherence, a goal that is particularly poignant given the emotional and financial stakes involved. The platform’s flexibility allows for rapid adjustments based on pilot feedback, a testament to Dr. Jones’s commitment to continuous improvement and adaptation.

In conversations about the future, Dr. Jones is both pragmatic and visionary. He acknowledges that Frontive will have to prove themselves in the fertility space, and is eager to do a pilot program with one forward thinking fertility clinic or network.

Ultimately, Dr. Jones’ work embodies a commitment to reshaping healthcare into a more intuitive, patient-centered experience. His journey from a disillusioned medical student to a pioneering tech entrepreneur reflects a deep-seated resolve to address systemic inefficiencies with innovative solutions.

In an industry often bogged down by inertia and skepticism, Dr. C. Anthony Jones’ story is one of relentless curiosity and a vision for a more coherent, compassionate healthcare system.


Exclusive Pilot Opportunity-FREE for One Group Only

Choosing only one fertility clinic or network, Frontive Health, led by Dr. C. Anthony Jones, wants to replicate the results they’ve achieved in other healthcare sectors in the fertility space.

  • 60% Reduction in Patient Questions

  • 25% Reduction In Nurse Time

  • 20% increase in patient satisfaction

Dr. Jones is willing to pilot Frontive Health’s program for free…. But for only one fertility clinic network.

One clinic or network will receive several thousand dollars in value for free, but they must be innovative leaders and have an integrative EMR.

To see if your group qualifies, simply e-mail Dr. Jones and say hello.

 
 

All external links active as of 09/05/2024

External links are being provided as a convenience and for informational purposes only; they do not constitute an endorsement or an approval by Fertility Bridge or Inside Reproductive Health of any of the products, services or opinions of the corporation or organization or individual. Neither Fertility Bridge nor Inside Reproductive Health bears responsibility for the accuracy, legality or content of the external site or for that of subsequent links. Contact the external site for answers to questions regarding its content.

 
 

Fertility Division Closures Raise Questions about Future of Genetics Companies

This News Digest Brought to You by
BUNDL

 
 
 

BY:  ALEXANDRA FROST

Major genetics companies downsized their fertility divisions in 2022 and 2023, causing speculation on the future of fertility testing. Genomic testing company Sema4, which recently changed names to GeneDx, another genetics company it acquired last year, administered a round of layoffs after 2022 quarter 2 results were announced. 

Again on November 14, 2022, they announced additional restructuring, cutting their reproductive health testing lab, approximately an additional 500 employees. CEO, Katherine Stueland, said in a call with investors, that the reproductive health testing business is “unsustainable,” pointing to capital market constraints in the macroeconomic climate. GeneDx didn’t respond to requests for comment on these layoffs. 

Similarly, in July 2022, genetic testing company Invitae announced layoffs of more than 1,000 employees, according to a U.S. Securities and Exchange Commission report. In addition, Invitae’s January 9, 2023 financial results from 2022 reflect a fourth-quarter decline “ due to the exited businesses and geographies,” compared to the previous year.  The Mercury News reported that Natera announced plans to lay off 58 people in November 2022.

In Invitae’s July 2022 business realignment strategy, they describe focusing on higher margin testing opportunities as part of a plan to realize $326 million in cost savings in 2023. Invitae responded with “no comment” for more information on these layoffs and changes.

The shift away from tests such as carrier screenings, noninvasive prenatal testing, among others, have fertility industry leaders examining what these strategy changes mean for the future of genetic testing.  “In terms of the genetics lab space right now, I would sum it up as the chickens are coming home to roost,” says Carrie Haverty, a genetic counselor who spent around 15 years working in reproductive health space seeing patients, and then moved into women's health product leadership roles at Counsyl, Myriad Women's Health, and now Mirvie

“This is happening now, versus the last five to seven years, because money is not as readily available to smooth over the gaps,”. Haverty points to a combination of “unfortunate business models — data isn’t valuable if you don’t have an actual plan to monetize it,” and macroeconomic cycles, in which she says investors are demanding some reasonable path to positive margins. In her December article “Genetic Testing Labs: Winter is Coming,” she expresses concern that if reproductive health was a major part of Sema4’s testing volume and revenue, where will growth come from? 

Christina Ren, board-certified genetic counselor turned life science investor, says “ [Sema4] cut reproductive health services to focus on pediatric and rare disease tests instead. Not all tests cost and are reimbursed the same, leading to discrepancies between different genomic specialties.” 

Former Sema4 Regional Sales Leader in the Women’s Health division, Brie McKeller, MPA, says she started to be alarmed about the company’s direction after hearing the mid-August shareholders call, and was abruptly notified of layoffs on November 14, 2022. She says Sema4 “has done a huge disservice to employees, but also to the IVF industry as a whole.” 

“More and more we saw other companies were going under that were doing women’s reproductive health testing. We came to find out, as a whole, the insurance industry was no longer allowing for these large payouts,” she says, noting that genetics companies didn’t have input with large payors. “That preempted the downfall of so many of these companies. They didn’t foresee insurance payors would no longer be paying these larger amounts, and would be consolidating which places they’re using.”

At the Sema4 shareholder call, McKeller says she was shocked to hear that the company was dealing with a $30 million revenue reversal. “It turns out, in an attempt to get in network with Blue Cross Blue Shield, Sema4 was at the helm of an internal audit by BCBS, only to find out that Sema4 overcharged them by $30 million between 2019 and February 2022.” McKeller says it felt like CEO Katherine Stueland “breezed over” the development which foreshadowed the eventual cuts. 

Haverty adds that reproductive health is typically poorly reimbursed, especially compared to oncology. Haverty says testing in the reproductive endocrinology/infertility space is often paid by wealthier patients. “Insurers do not place a high value on reproductive health outcomes, particularly when the issue would either result in [the loss of the baby or pregnancy]  at no cost to the [insurer].  [If the issue] results in a serious condition later,it’s unlikely [the insurance company] will still have that patient under their care given the average turnover is less than 2 years,” she says. “Why pay for something that won't deliver an ROI for [the insurance company], but rather for some other payor — and often a government payor?”

As stakeholders watch the future of genetics testing unfold, some, like Ren are still optimistic. “It's not about altruism; it's about good businesses that can make a positive impact. In a time dominated by short-termism, there's more value than ever in building for the long term. Cancer doesn’t care about inflation and rising interest rates. Infertility doesn’t care when earnings season is. There are real problems to be solved regardless of the macro environment.”

Dr. Mili Thakur, Triple board certified in obstetrics and gynecology, reproductive endocrinology/infertility and medical genetics, adds that clinicians' reliance on genetic testing companies for their genetic counseling needs is “not sustainable.”

“The drivers for for-profit commercial companies are financial, while the driver for clinicians is good patient care,” she says. “The field of reproductive genetics will keep on expanding. If we strengthen our clinical genetic practice and highlight its importance, genetic testing companies and stakeholders will have to acknowledge that this field of genetics is essential, enabling adequate support for this specialty.”

When asked to remark on the future of genetic testing companies in the reproductive medicine space, Progenesis did not respond to a request for comment and Natera declined to comment.

The themes reported in this publication are those of the news. They do not reflect the views of Inside Reproductive Health, nor of the Advertiser


New Patient Visits Drop, IVF Centers Seek Strategy

Different fertility centers across the United States have started to see new patient volumes decrease.

To counter the decrease in new patient revenue, fertility centers are turning to partners who have IVF-ready, financially qualified patients, but who don’t yet have a fertility clinic.

Courtney from BUNDL has a list of treatment-ready patients in each city. There is no fee but the offer is for the US and Canada only. 


 
 

All external links active as of 2/2/23.

External links are being provided as a convenience and for informational purposes only; they do not constitute an endorsement or an approval by Fertility Bridge or Inside Reproductive Health of any of the products, services or opinions of the corporation or organization or individual. Neither Fertility Bridge nor Inside Reproductive Health bears responsibility for the accuracy, legality or content of the external site or for that of subsequent links. Contact the external site for answers to questions regarding its content.